NeuroTherapia raised $12.3M in the first close of its Series B financing led by Cleveland Clinic to continue developing an orally available treatment for Alzheimer's disease.
Amount Raised
$12.3 Million
Round Type
Series B
ClevelandBiotechnologyHealth CareTherapeuticsInvestors
Description
NeuroTherapia, Inc. announced the first closing of its Series B financing with $12.3M in funding. This investment will primarily be used for the clinical development of NTRX-07, aimed at treating Alzheimer's disease.
Quick answer
NeuroTherapia raised $12.3 Million in a Series B round, dated August 6, 2024. Investors: Alzheimer’s Drug Discovery Foundation, Cruint, Foundation For A Better World, Dolby Family Ventures, Brain Trust Accelerator Fund Ii and Cleveland Clinic. NeuroTherapia is based in Cleveland, Ohio, United States.
- How much did NeuroTherapia raise?
- NeuroTherapia raised $12.3 Million in a Series B round on August 6, 2024.
- Who invested in NeuroTherapia?
- Alzheimer’s Drug Discovery Foundation, Cruint, Foundation For A Better World, Dolby Family Ventures, Brain Trust Accelerator Fund Ii and Cleveland Clinic are named as investors in this round.
- What does NeuroTherapia do?
- NeuroTherapia is a clinical-stage, privately held biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system (CNS), including Alzheimer's disease,..
- Where is NeuroTherapia based and how big is it?
- NeuroTherapia is based in Cleveland, Ohio, United States. Fundz records about 7 employees.
- Who are the decision-makers at NeuroTherapia?
- Fundz holds 1 contact at NeuroTherapia. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as NeuroTherapia that raised within 45 days of this round, from Fundz verified event records.
- Aktis Oncology raised $175M on September 20, 2024.
- CTRL Therapeutics raised $9.1M on September 19, 2024.
- Brenus Pharma raised $25M (Series A) on September 18, 2024.
- Vaccinex raised $200K (Seed) on September 18, 2024.
- Dermata Therapeutics raised $3.5M (Seed) on September 17, 2024.
- ImmunOs Therapeutics AG raised $11M (Series C) on September 17, 2024.
Who to call at NeuroTherapia, and when
A new round usually means NeuroTherapia is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NeuroTherapia raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NeuroTherapia, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NeuroTherapia. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NeuroTherapia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNeuroTherapia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.